{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:15:31Z","timestamp":1792815331598,"version":"4.5.0"},"reference-count":78,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cancer Science"],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chemotherapy for non\u2010Hodgkin lymphoma (NHL) in the hemodialysis (HD) patient is a challenging situation. Because many drugs are predominantly eliminated by the kidneys, chemotherapy in the HD patient requires special considerations concerning dose adjustments to avoid overdose and toxicities. Conversely, some drugs are removed by HD and may expose the patient to undertreatment, therefore the timing of drug administration in relation to HD sessions must be carefully planned. Also, the metabolites of some drugs show different toxicities and dialysability as compared with the parent drug, therefore this must also be catered for. However, the pharmacokinetics of many chemotherapeutics and their metabolites in HD patients are unknown, and the fact that NHL patients are often treated with distinct multiagent chemotherapy regimens makes the situation more complicated. In a realm where uncertainty prevails, case reports and case series reporting on actual treatment and outcomes are extremely valuable and can aid physicians in decision making from drug selection to dosing. We carried out an exhaustive review of the literature and adopted 48 manuscripts consisting of 66 HD patients undergoing 71 chemotherapy regimens for NHL, summarized the data, and provide recommendations concerning dose adjustments and timing of administration for individual chemotherapeutics where possible. The chemotherapy regimens studied in this review include, but are not limited to, rituximab, cyclophosphamide\u00a0+\u00a0vincristine\u00a0+\u00a0prednisolone (CVP) and cyclophosphamide\u00a0+\u00a0doxorubicin\u00a0+\u00a0vincristine\u00a0+\u00a0prednisolone (CHOP)\u2010like regimens, chlorambucil, ibrutinib, bendamustine, methotrexate, platinum compounds, cytarabine, gemcitabine, etoposide, ifosfamide, melphalan, busulfan, fludarabine, mogamulizumab, brentuximab vedotin, and <jats:sup>90<\/jats:sup>Y\u2010ibritumomab tiuxetan.<\/jats:p>","DOI":"10.1111\/cas.14933","type":"journal-article","created":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T08:01:00Z","timestamp":1620028860000},"page":"2607-2624","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Chemotherapy for non\u2010Hodgkin lymphoma in the hemodialysis patient: A comprehensive review"],"prefix":"10.1111","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2896-7737","authenticated-orcid":false,"given":"Hajime","family":"Yasuda","sequence":"first","affiliation":[{"name":"Department of Hematology Juntendo University School of Medicine Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutsuko","family":"Yasuda","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism Tokyo Metropolitan Bokutoh Hospital Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1880-9126","authenticated-orcid":false,"given":"Norio","family":"Komatsu","sequence":"additional","affiliation":[{"name":"Department of Hematology Juntendo University School of Medicine Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,6,11]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30531"},{"issue":"12","key":"e_1_2_8_3_1","first-page":"1808","article-title":"Acute kidney injury secondary to lymphomatous infiltration and the role of kidney biopsy","volume":"29","author":"Alkhunaizi AM","year":"2008","journal-title":"Saudi Med J"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1115033"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp598"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2017-000167"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-008-9064-0"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2017.1323632"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2009.150"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200443080-00002"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.10213"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.49.4018"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(72)90124-2"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.6116.820-a"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00850225"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-004-1521-1"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.5414\/CNP71198"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndtplus\/sfr181"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.5414\/CNCS109036"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2020.10.007"},{"issue":"6","key":"e_1_2_8_21_1","first-page":"480","article-title":"Malignant lymphoma of the kidney mimicking rapid progressive glomerulonephritis","volume":"74","author":"Weng SC","year":"2010","journal-title":"Clin Nephrol"},{"issue":"5","key":"e_1_2_8_22_1","article-title":"Spontaneous tumor lysis syndrome in diffuse large B\u2010cell lymphoma: Early diagnosis and management","volume":"11","author":"Gangireddy M","year":"2019","journal-title":"Cureus"},{"issue":"3","key":"e_1_2_8_23_1","first-page":"301","article-title":"Primary non\u2010Hodgkin's lymphoma of the kidney","volume":"74","author":"Paganelli E","year":"1989","journal-title":"Haematologica"},{"issue":"1","key":"e_1_2_8_24_1","first-page":"59","article-title":"Continuous veno\u2010venous hemodiafiltration for the treatment of spontaneous tumor lysis syndrome complicated by acute renal failure and severe hyperuricemia","volume":"54","author":"Agha\u2010Razii M","year":"2000","journal-title":"Clin Nephrol"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/hdi.12229"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2016.1190977"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1159\/000350746"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2257.2006.00879.x"},{"issue":"4","key":"e_1_2_8_29_1","first-page":"338","article-title":"Acute kidney injury requiring dialysis: a very unusual presentation of non\u2010Hodgkin's lymphoma","volume":"3","author":"Jorge S","year":"2010","journal-title":"NDT Plus"},{"issue":"3","key":"e_1_2_8_30_1","first-page":"186","article-title":"Successful treatment of non\u2010Hodgkin's lymphoma with rituximab and dose\u2010adjusted CHOP therapy in a patient with concomitant end\u2010stage renal disease requiring haemodialysis","volume":"4","author":"Kawano N","year":"2011","journal-title":"NDT Plus"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/17843286.2016.1178967"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.4103\/1319-2442.206459"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/nep.12925"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1136\/bcr\u20102018\u2010226328"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2019.11.004"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2013.783213"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199205000-00032"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.5414\/CNP61422"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-008-0777-8"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14718"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-016-2607-0"},{"key":"e_1_2_8_42_1","first-page":"3732902","article-title":"Waldenstrom's macroglobulinemia: A report of two cases, one with severe retinopathy and one with renal failure","volume":"2017","author":"Kudo N","year":"2017","journal-title":"Case Rep Hematol"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1177\/1078155217754244"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2009.01.016"},{"issue":"1","key":"e_1_2_8_45_1","first-page":"66","article-title":"High dose methotrexate and extended hours high\u2010flux hemodialysis for the treatment of primary central nervous system lymphoma in a patient with end stage renal disease","volume":"2","author":"Mutsando H","year":"2012","journal-title":"Am J Blood Res"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01709664"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-010-1373-2"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00695995"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1159\/000189006"},{"issue":"4","key":"e_1_2_8_50_1","first-page":"757","article-title":"Safety of fractionated dose of rituximab in renal failure patients receiving hemodialysis","volume":"47","author":"Ostronoff F","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.4274\/tjh.2014.0166"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2019.07.443"},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702112"},{"key":"e_1_2_8_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-008-0578-5"},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2016.1211280"},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-81488-4_16"},{"key":"e_1_2_8_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-013-1513-2"},{"key":"e_1_2_8_58_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-003-0574-3"},{"key":"e_1_2_8_59_1","doi-asserted-by":"publisher","DOI":"10.1155\/2009\/575629"},{"key":"e_1_2_8_60_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.03033.x"},{"key":"e_1_2_8_61_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.65.0044"},{"key":"e_1_2_8_62_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1977224430"},{"key":"e_1_2_8_63_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00686499"},{"issue":"2","key":"e_1_2_8_64_1","first-page":"226","article-title":"Clinical pharmacology of cyclophosphamide","volume":"33","author":"Bagley CM","year":"1973","journal-title":"Cancer Res"},{"key":"e_1_2_8_65_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200544110-00003"},{"key":"e_1_2_8_66_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.114.060061"},{"key":"e_1_2_8_67_1","doi-asserted-by":"publisher","DOI":"10.1179\/acb.2006.028"},{"key":"e_1_2_8_68_1","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e3181a61f2d"},{"key":"e_1_2_8_69_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1989.7.11.1748"},{"key":"e_1_2_8_70_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600687"},{"key":"e_1_2_8_71_1","doi-asserted-by":"publisher","DOI":"10.1159\/000065582"},{"key":"e_1_2_8_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clcc.2014.09.003"},{"key":"e_1_2_8_73_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1991.9.3.491"},{"issue":"1","key":"e_1_2_8_74_1","first-page":"379","article-title":"Pharmacokinetics of high\u2010dose etoposide (VP\u201016\u2010213) administered to cancer patients","volume":"44","author":"Hande KR","year":"1984","journal-title":"Cancer Res"},{"issue":"11","key":"e_1_2_8_75_1","first-page":"1279","article-title":"Pharmacokinetic evaluation of increasing dosages of etoposide in a chronic hemodialysis patient","volume":"69","author":"Holthuis JJ","year":"1985","journal-title":"Cancer Treat Rep"},{"key":"e_1_2_8_76_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1996.135"},{"key":"e_1_2_8_77_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12988"},{"key":"e_1_2_8_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2007.08.050"},{"key":"e_1_2_8_79_1","doi-asserted-by":"publisher","DOI":"10.1081\/CNV-120005903"}],"container-title":["Cancer Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cas.14933","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/cas.14933","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cas.14933","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T02:57:22Z","timestamp":1693191442000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cas.14933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,11]]},"references-count":78,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["10.1111\/cas.14933"],"URL":"https:\/\/doi.org\/10.1111\/cas.14933","archive":["Portico"],"relation":{},"ISSN":["1347-9032","1349-7006"],"issn-type":[{"value":"1347-9032","type":"print"},{"value":"1349-7006","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,11]]},"assertion":[{"value":"2021-03-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}